Literature DB >> 35261851

Lemierre's syndrome complicated by cerebral venous sinus thrombosis: A life threatening and rare disease successfully treated with empiric antimicrobial therapy and conservative approach.

Maurizio Giorelli1, Sergio Altomare1, Maria Stella Aniello1, Ruggiero Leone1, Daniele Liuzzi1, Immacolata Plasmati1, Michele Sardaro1, Maria Superbo1, Giuseppe Mennea2, Nicola Fioretto3, Giuseppe Guglielmi3, Rosario Balzano3, Tommaso Scarabino4, Giuseppe Cuccorese5, Francesca Cialdella6, Giuseppe Campobasso6, Michele Barbara6.   

Abstract

Lemierre's syndrome (LS) is a "forgotten" condition characterized by septic thrombophlebitis of the jugular vein that follows an otolaryngological infection. Fusobacterium necrophorum is the aetiological agent responsible for the syndrome in adolescents and young adults whereas in older people even common bacteria are involved. Complications arise from spreading of septic emboli distally, i.e. to the brain, lungs, bones and internal organs everywhere in the body. We report a middle-aged woman who presented with headache and bilateral sixth cranial nerve palsy following a sphenoidal sinusitis and left mastoiditis. Imaging revealed thrombotic involvement of the left internal jugular vein as well as of several cerebral venous sinuses thrombosis (CVT). Currently, precise management protocols of LS with CVT complication do not exist although a combination of macrolides and second or third-generation cephalosporins, as well as anti-coagulants represent the mainstream of therapeutics. Surgical drainage is associated to remove septic foci but is burdened by severe complications and side effects. Complete recovery was achieved following pharmacological treatment in our patient. This report adds further evidence that LS complicated by CVT may be effectively treated adopting a conservative approach thus avoiding surgical drainage and severe complications. 2022, International Research and Cooperation Association for Bio & Socio - Sciences Advancement.

Entities:  

Keywords:  cerebral venous circulation; jugular vein thrombosis; otomastoiditis; sinusitis

Year:  2022        PMID: 35261851      PMCID: PMC8898395          DOI: 10.5582/irdr.2021.01142

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  8 in total

1.  Cerebral venous sinus thrombosis secondary to otomastoiditis.

Authors:  Mauricio F Villamar; Jessica D Lee
Journal:  Postgrad Med J       Date:  2017-01-25       Impact factor: 2.401

2.  Cerebral venous thrombosis.

Authors:  José Manuel Ferro; Patrícia Canhão; Diana Aguiar de Sousa
Journal:  Presse Med       Date:  2016-11-02       Impact factor: 1.228

Review 3.  Human necrobacillosis, with emphasis on Lemierre's syndrome.

Authors:  L Hagelskjaer Kristensen; J Prag
Journal:  Clin Infect Dis       Date:  2000-09-14       Impact factor: 9.079

4.  Lateral sinus thrombosis as a complication of otitis media: 10-year experience at the children's hospital of Philadelphia.

Authors:  Christina B Bales; Steven Sobol; Ralph Wetmore; Lisa M Elden
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

5.  Torcular herophili and lateral sinus thrombosis: An atypical presentation of Lemièrre's syndrome.

Authors:  Jesús Baltasar-Corral; Reyes María Martín-Rojas; Alejandro Parra-Virto; Francisco Galeano-Valle; Mariano Del-Valle-Diéguez; Jorge Del-Toro-Cervera; Pablo Demelo-Rodríguez
Journal:  Intractable Rare Dis Res       Date:  2019-08

6.  Inflammation is correlated with severity and outcome of cerebral venous thrombosis.

Authors:  Liyan Wang; Jiangang Duan; Tingting Bian; Ran Meng; Longfei Wu; Zhen Zhang; Xuxiang Zhang; Chunxiu Wang; Xunming Ji
Journal:  J Neuroinflammation       Date:  2018-11-26       Impact factor: 8.322

7.  Lemierre's syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey.

Authors:  L Hagelskjaer Kristensen; J Prag
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-11       Impact factor: 3.267

Review 8.  Lemierre's syndrome: current perspectives on diagnosis and management.

Authors:  Katrine M Johannesen; Uffe Bodtger
Journal:  Infect Drug Resist       Date:  2016-09-14       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.